Their effect has not been precisely studied, but their exclusivity with the GNAQ, GNA11, and CYSLTR2 mutations and PLCβ4 being downstream of these proteins suggest that PLCβ4 mutations have a similar effect on the oncogenicity of uveal melanomas [177]. The gene discussed is PLCB4; the disease is uveal melanoma.